BIOM-39. P-ERK ASSOCIATION WITH OVERALL SURVIVAL IN RECURRENT GBM PATIENTS TREATED WITH INTRACEREBRAL ADMINISTRATION OF PD-1 AND CTLA-4 BLOCKING ANTIBODIES

Authors: Victor Arrieta, Johnny Duerinck, Kirsten B Burdett, Wietse Geens, Julia Katharina Schwarze, Andrew Gould, Li Chen, Matthew McCord, Craig Horbinski, Hui Zhang, Roger Stupp, Bart Neyns, Adam M Sonabend

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.049

Source: Full article


Abstract

Abstract